Does RABEPRAZOLE Cause Hyperparathyroidism secondary? 108 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Hyperparathyroidism secondary have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 1.0% of all adverse event reports for RABEPRAZOLE.
108
Reports of Hyperparathyroidism secondary with RABEPRAZOLE
1.0%
of all RABEPRAZOLE reports
22
Deaths
30
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From RABEPRAZOLE?
Of the 108 reports, 22 (20.4%) resulted in death, 30 (27.8%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
SODIUM, DIBASIC\SODIUM, MONOBASIC (45)
Which RABEPRAZOLE Alternatives Have Lower Hyperparathyroidism secondary Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR